Company Filing History:
2 out of 36 
2 out of 26 Years Active: 2007-2009
Title: Ruth Geva: Innovator in Pharmaceutical Compositions
Introduction
Ruth Geva is a prominent legal representative and inventor based in Jerusalem, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for cancer. With a total of two patents to her name, her work has the potential to impact the medical community profoundly.
Latest Patents
Ruth Geva's latest patents focus on verotoxin pharmaceutical compositions and medical treatments. These compositions, which include known verotoxins such as verotoxin 1, have been found to be effective in treating mammalian neoplasia, specifically ovarian cancer and skin cancer. Remarkably, while verotoxin 1 has demonstrated anti-neoplastic activity in vitro, non-lethal doses have shown therapeutic anti-neoplastic effects in vivo.
Career Highlights
Throughout her career, Ruth has worked with notable organizations, including HSC Research and Development Limited Partnership and the Ontario Cancer Institute. Her expertise in legal representation and her innovative approach to pharmaceutical development have established her as a key figure in her field.
Collaborations
Ruth Geva has collaborated with esteemed colleagues such as Clifford A. Lingwood and Leorah Kroyanker, who also serve as legal representatives. These partnerships have further enhanced her contributions to the pharmaceutical industry.
Conclusion
Ruth Geva's work in developing verotoxin-based pharmaceutical compositions showcases her dedication to advancing medical treatments for cancer. Her innovative spirit and collaborative efforts continue to pave the way for future breakthroughs in the field.